AIHTA - Publications - Search - Atezolizumab (Tecentriq®) plus bevacizumab for the treatment of advanced or unresectable hepatocellular carcinoma (HCC)

Grössmann, N. (2020): Atezolizumab (Tecentriq®) plus bevacizumab for the treatment of advanced or unresectable hepatocellular carcinoma (HCC). Oncology Fact Sheet Nr. 20.

[thumbnail of Oncology Fact Sheet Nr.20.pdf]
Preview
PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
83kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WI Digestive system > WI 700-770 Liver. Billary tract
Language:English
Series Name:Oncology Fact Sheet Nr. 20
Deposited on:29 Oct 2020 12:35
Last Modified:29 Oct 2020 12:35

Repository Staff Only: item control page